- Home
- TNC vs VCEL Comparison
TNC vs VCEL Comparison
Compare TNC & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNC
- VCEL
- Stock Information
- Founded
- TNC 1870
- VCEL 1989
- Country
- TNC United States
- VCEL United States
- Employees
- TNC N/A
- VCEL N/A
- Industry
- TNC Industrial Machinery/Components
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TNC Industrials
- VCEL Health Care
- Exchange
- TNC Nasdaq
- VCEL Nasdaq
- Market Cap
- TNC 1.5B
- VCEL 1.6B
- IPO Year
- TNC N/A
- VCEL 1997
- Fundamental
- Price
- TNC $80.00
- VCEL $35.06
- Analyst Decision
- TNC Strong Buy
- VCEL Strong Buy
- Analyst Count
- TNC 2
- VCEL 6
- Target Price
- TNC $113.50
- VCEL $58.60
- AVG Volume (30 Days)
- TNC 68.9K
- VCEL 578.6K
- Earning Date
- TNC 11-03-2025
- VCEL 11-06-2025
- Dividend Yield
- TNC 1.48%
- VCEL N/A
- EPS Growth
- TNC N/A
- VCEL 2045.40
- EPS
- TNC 3.20
- VCEL 0.13
- Revenue
- TNC $1,253,300,000.00
- VCEL $249,119,000.00
- Revenue This Year
- TNC N/A
- VCEL $18.35
- Revenue Next Year
- TNC $4.93
- VCEL $22.26
- P/E Ratio
- TNC $24.97
- VCEL $262.52
- Revenue Growth
- TNC N/A
- VCEL 16.13
- 52 Week Low
- TNC $67.32
- VCEL $29.24
- 52 Week High
- TNC $94.87
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- TNC 45.13
- VCEL 51.82
- Support Level
- TNC $80.28
- VCEL $35.47
- Resistance Level
- TNC $82.79
- VCEL $36.99
- Average True Range (ATR)
- TNC 1.70
- VCEL 1.52
- MACD
- TNC -0.00
- VCEL -0.01
- Stochastic Oscillator
- TNC 43.82
- VCEL 52.81
About TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.